Table 1: Comparison of participants' menstrual changes with the COVID-19 vaccine type.
|
Menstruation change |
Pfizer-BioNTech (n:533) |
Sinovac (n:60) |
Toplam (n:593) |
Test value |
|||||
|
n |
% |
n |
% |
n |
% |
X2/t |
p |
||
|
Side effect of the vaccine |
|||||||||
|
Yes |
192 |
36.0 |
7 |
11.7 |
199 |
33.6 |
14.348 |
0.000 |
|
|
No |
341 |
64.0 |
53 |
88.3 |
394 |
66.4 |
|||
|
Post-vaccine dysmenorrhea |
|||||||||
|
Yes |
395 |
74.1 |
45 |
75.0 |
440 |
74.2 |
0.022 |
0.881 |
|
|
No |
138 |
25.9 |
15 |
25.0 |
153 |
25.8 |
|||
|
Post-vaccine dysmenorrhea time |
|||||||||
|
During menstruation after the first vaccination |
318 |
59.7 |
39 |
65.0 |
357 |
60.2 |
1.034 |
0.596
|
|
|
During menstruation after the second vaccination |
77 |
14.4 |
6 |
10.0 |
83 |
14.0 |
|||
|
No post-vaccine dysmenorrhea |
138 |
25.9 |
15 |
25.0 |
153 |
25.8 |
|||
|
Effect of the vaccine on the menstrual cycle |
|||||||||
|
Yes |
137 |
25.7 |
10 |
16.7 |
147 |
24.8 |
2.362 |
0.432 |
|
|
No |
396 |
74.3 |
50 |
83.3 |
446 |
75.2 |
|||
|
Increase in menstrual days after vaccination |
|
|
|||||||
|
Yes |
59 |
11.1 |
5 |
8.3 |
64 |
10.8 |
0.419 |
0.517 |
|
|
No |
474 |
88.9 |
55 |
91.7 |
529 |
89.2 |
|||
|
Increase in menstrual bleeding after vaccination |
|
|
|||||||
|
Yes |
66 |
12.4 |
4 |
6.7 |
70 |
11.8 |
1.693 |
0.193 |
|
|
No |
467 |
87.6 |
56 |
93.3 |
523 |
88.2 |
|||
*X2: Chi-square analysis, t: Independent Samples Test, p < 0.05